The Rice Biotech Launch Pad and RBL LLC will hold an event to celebrate the official launch and lab opening of RBL LLC May 5, following a Rice presidential lecture delivered by Robert Langer Jr. The launch event, held at Helix Park, will also feature a keynote a keynote presentation by Robert Ruffolo Jr.
Rice statistician Erzsébet Merényi is part of a team of researchers awarded $1 million by the Cancer Prevention and Research Institute of Texas to develop AI tools that can identify lethal forms of prostate cancer earlier and improve treatment selection.
A recent symposium organized by the ENRICH office and the Rice Neuroengineering Initiative as part of the Meeting of the Minds NeuroNetworking Series explored ethics and policy in brain science today, including in the context of psychedelic-assisted therapy.
Through an eight-week immersive experience, Rice students observed complex clinical environments at Texas Children’s Hospital and the Texas Heart Institute, identifying unmet health care needs and exploring solutions with a human-centered approach.
As a partner institution of the Center for Clinical and Translational Sciences at UTHealth Houston, Rice has received approximately $1.69 million in grant funding to support pilot projects, student training and collaborative research in bioengineering, informatics, team science and related areas.
The Rice lab of bioengineer Gang Bao and collaborators at Baylor College of Medicine have developed a new gene-editing strategy that dramatically boosts the effectiveness of gene therapies in the liver, a breakthrough that could lead to new treatments for about 700 genetic disorders in this vital organ as well as in other organs and tissues.
Rice scientists and collaborators at Baylor College of Medicine have demonstrated a new method for detecting the presence of dangerous chemicals from tobacco smoke in human placentas with unprecedented speed and precision.
Four Rice research groups are part of an inaugural cohort of 18 projects funded by the U.K.’s Advanced Research and Invention Agency to unlock cutting-edge brain-interfacing technologies.
In Houston’s Texas Medical Center Helix Park, RBL LLC is transforming the path from scientific discovery to lifesaving therapies. This new biotech venture creation studio is designed to rapidly build companies around cutting-edge innovations from Rice University’s Biotech Launch Pad, aiming to bring advanced treatments to patients faster and more efficiently.
Seven research partnerships involving Rice, the Baker Institute for Public Policy and various institutions within the Texas Medical Center (TMC) received seed grants in 2024 through the Provost’s TMC Collaborator Fund. These grants were facilitated by Rice’s office for Educational and Research Initiatives for Collaborative Health (ENRICH).
Rice and Houston Methodist have joined forces to establish the Digital Health Institute aimed at transforming health care for millions through advanced technology and collaborative expertise.
Senior officials from the Cancer Prevention and Research Institute of Texas visited Rice Nov.11 for a firsthand, comprehensive look at the university’s cancer-focused collaborative research initiatives and innovation-driven facilities and labs.
The Educational and Research Initiatives for Collaborative Health (ENRICH) at Rice University and The Bookout Center at Houston Methodist hosted the first joint faculty engagement event aimed at fostering collaboration between researchers at the two institutions.
Leaders and researchers from Rice and the University of Texas MD Anderson Cancer Center came together this month to celebrate the launch of the Cancer Bioengineering Collaborative, first announced earlier this summer.
Rice has launched RBL LLC, a pioneering biotech venture creation studio designed to rapidly build companies based on lifesaving medical technologies developed out of the Rice Biotech Launch Pad.